Single-domain antibodies, or “nanobodies,” inspired by llamas, have been proposed as potential treatments for COVID-19. Now, one company’s candidates have shown early promise in animal models.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,